BioSpace News Archive

EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, announced today the results of a randomized controlled clinical study conducted at the University of Chicago, which found significant benefit to low-risk patients who are not woken during the night for vital sign assessments.

New Ventures BC and BioTalent Canada today announced a new partnership to assist BC biotech companies to access funding to hire post-secondary students for business and tech roles to help drive their objectives forward.

Tufts Health Freedom Plan has launched a new mobile application that will give members the ability to check claims and benefits, shop for coverage, and search for providers.

In a joint effort to promote the growth of Arizona’s optics industry, Arizona Technology Council member Strategy1 today announced it has been awarded a Small Business Association (SBA) contract.

Zarrow Pointe, Tulsa’s leading retirement community for seniors, has launched a peer-mentoring program for the development and advancement of its team of certified nursing assistants (CNAs) in partnership with the National Association of Healthcare Assistants (NAHCA)

Preterm infants must establish regular breathing patterns at delivery. For extremely preterm infants requiring resuscitation at birth, a ventilation strategy involving two sustained inflations, compared with standard intermittent positive pressure ventilation, did not reduce the risk of bronchopulmonary dysplasia (BPD) or death at 36 weeks postmenstrual age.

Managing access to gene therapy, mitigating risk of inappropriate opioid utilization, the current state of value-based contracting, and drug pricing reform efforts are just some topics of the nearly 40 educational sessions taking place at the Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting this week in San Diego.

On March 26, 2019, the global leading peptide supplier Creative Peptides announced to update its therapeutic peptides for researchers who are dedicated to finding a cure for many diseases in the pharmaceutical industry

μLOT® is an entirely new approach to manufacturing of therapeutic peptides, which promises to completely replace traditional large scale batch manufacturing.

Ophthalmic medical device companyImplandata Ophthalmic Products GmbH (Implandata) announced today it successfully attained CE mark for its next generation EYEMATE-IO 1.1 implantable micro-sensor, which will be launched in April 2019.